Latest prices for Everolimus

Everolimus (Everolimus) is a drug that belongs to the class of immunosuppressants. It is an oral preparation commonly used to prevent organ rejection after organ transplantation and to treat certain types of cancer.

Everolimus has been approved for marketing in my country, and has been included in the national medical insurance. The price is about 4000~5000 yuan. It takes about 2 boxes of everolimus per month. For specific prices and medical insurance reimbursement policies, please consult the local hospital pharmacy or medical insurance bureau. The cheaper ones abroad are mainly Indian generic drugs, the price is around 700~1,500yuan, and the ingredients of the drugs are basically the same as those in China.

Everolimus is used as an immunosuppressant after organ transplantation. When patients receive an organ transplant (such as a heart, kidney, liver, etc.), their immune system may attempt to reject the foreign organ. Everolimus suppresses the immune response and reduces the risk of organ rejection, helping the patient's body accept the new organ.

Everolimus is also used to treat certain types of cancer, such as breast cancer, renal cell carcinoma, neuroendocrine tumors, etc. It is a targeted therapy drug that blocks the growth and spread of cancer cells by inhibiting cell growth signaling pathways.

In addition, everolimus is also used in drug-coated stents for the treatment of coronary artery stenosis. In this application, everolimus is coated on a coronary stent to reduce the risk of in-stent re-stenosis by inhibiting tissue growth.

Although everolimus has many advantages, it can also cause some side effects and adverse reactions. Therefore, patients taking everolimus need to be monitored closely and follow their doctor's instructions. Any questions or concerns about everolimus should be consulted with a medical professional for appropriate advice and treatment.